click below
click below
Normal Size Small Size show me how
AnticancerDrugs
lecture 5-6 goodman
Question | Answer |
---|---|
2 most important checkpoint controls in the cell cycle | G1-S checkpoint and the G2-M checkpoint |
ca with shorter doubling time = easier to cure | leukemias respond better to anti-ca tx than colon carcinomas, which have a larger doubling time |
types of normal cells that might be killed with chemotx | hair follicle cells, colonic crypts and bone marrow |
antimetabolites kill cells that are in ___ phase during exposure | S phase |
vinca alkaloids kill cells that are in ____ phase during drug exposure | M phase |
phase non-specific drugs | kill cycling cells regardless of the phase they are in during exposure; cells will actually be killed in the S PHASE thus they are GROWTH-DEPENDENT drugs |
first-order cell killing or logarithmic kill | when giving a dose of chemotx, 99% of cells will be killed with each round, fixed percentage die |
What area of tumor has the slowest growing cells? | cells further away from the surface of the tumor aka in the core |
Why use multi-drug therapy? | tumor cells can develop resistance by inducing production of a multi-drug resistance pump, for example, or duplicating genes like the DHFR gene |
typical toxicities of anti-ca tx | GI: mucositis, nausea, cells dying in intestinal crypts // Heme: anemia, bleeding, myelosupression (give erythropoietin) // Hair: follicular cells die, hair falls out |
types of drugs that interfere with DNA | antimetabolites, alkylating drugs, those which interrupt with topoisomerases |
antimetabolite class | interfere with synthesis of normal nucleic acids; work as triphosphonucleotides to inhibit DNA polymerase or cause chain termination |
purine analogs | mercaptopurine (hypoxanthine) and thioguanine (guanine) are analogs that work to deplete cells of purine nucleotides |
5-FU | S PHASE DRUG - activated to 5-FdUMP, which inhibits thymidylate synthase and starves cells of thymidine. resistance by altering TSase, causes myelosuppression and hair loss |
capecitabine | prodrug that is metabolized to 5-FU in cells, ORAL DRUG |
cytarabine | S PHASE DRUG, block btwn G1 and S - cytosine analog with arabinose instead of ribose, inhibits chain elongation, resistance by more cytidine deaminase. BEST tx for AML |
methotrexate | S PHASE DRUG - analog of folic acid that binds with very high affinity to DHFR, depletes building blocks for DNA & RNA synthesis. use for leukemias & choriocarcinoma, resistance by upregulating salvage pathways |
drug given to "rescue" pt after high doses of methotrexate | leucovorin - fully reduced folate coenzyme that helps to restore folic acid precursors in cells |
hydroxyurea | erythrosuppressive that inhibits ribonucleoside reductase, useful for leukemias and lymphomas. also for sickle cell crises, very toxic |
alkylating agents | cyclize to generate positively charged reactive intermediates that can be attacked by lone pairs of electrons on N or O of DNA forming crosslinked strands; cells enter S phase with damaged DNA and die |
prototype of alkylating agents | mechlorethamine |
cyclophosphamide | useful oral alkylating agent, is inactive until first pass through liver, can cause hemorrhagic cystitis |
anthracyclines | planar tetracycline ring that intercalates btwn stacks of bases in DNA, reduced within cells and makes ROS, interferes with topoisomerase type II |
adverse effects of alkylating agents | severe bone marrow suppression with high tendency for development of leukemias and lymphomas yrs later, mucositis, possible bacterial sepsis, amenorrhea and azoospermia |
platinum complexes | non-classical alkylators that crosslink DNA, bifunctional agents that can react with guanines on same or different DNA strands; good use for solid tumors like testicles or ovaries |
cisplatin | platinum complex; administered IV and is very nephrotoxic if not hydrated, ototoxicity and peripheral neuropathy, myelosuppression |
unique adverse effect of anthracyclines | cardiomyopathy that is usually irreversible, occurs in up to 33% of pts taking these drugs |
doxorubicin (Adriamycin) | anthracycline that treats wide range of tumors |
bleomycin | G2 SPECIFIC DRUG: mixture of drugs that are complex glycopeptide antibiotics, chelate iron and copper and bind to DNA leading to redox radicals that cause multiple strand breaks and chr aberrations |
adverse reactions of bleomycin | pulmonary fibrosis (Lance Armstrong didn't want to take it), one of the few drugs that is NOT TOXIC TO BONE MARROW |
anti-topoisomerase agents | irinotecan (binds topo I, DS breaks during S phase metabolized to active drug SN-38, eliminated by glucuronidation) // etoposide (inhibits topo II causing DNA breaks) |
antimicrotubule agents | act on microtubules to block cell progression through mitosis --- classes are taxanes and vinca alkaloids |
vincristine and vinblastine | M PHASE AGENTS: bind tubulin alpha-beta heterodimers that stop formation of microtubules, cuase myelosuppression and neurotoxicity. vinblastine best for testicular ca, solid tumors |
vincristine | primarily for childhood leukemias and lymphomas, worst side effect is peripheral neuropathy that can cause paresthesias or anesthesias |
paclitaxel (Taxol) | binds preferentially to beta tubulin of existing microtubules and stops their disassembly, inhibits mitosis, good for breast and ovarian ca. can cause neuropathy |
prednisone | synthetic glucocorticoid used for tx of leukemia |
tamoxifen | SERM or selective estrogen receptor modulator; binds competitively with estrogen on ER+ breast ca cells; approved for prophylaxis of ER-sensitive breast ca in women with BRCA1 or 2 gene mutations |
how to reduce the endogenous sex steroid production when treating hormone-sensitive breast or prostate ca | oophorectomy/orchiectomy and treatment with a GnRH analog |
anastrozole | aromatase inhibitor that stops peripheral estradiol production from adipose tissue to as to starve the hormone-sensitive breast ca |
flutamide | anti-androgen used in combo with GnRH agonist to safely cause a chemical castration for tx of prostate ca |
leuprolide | potent GnRH agonist, causes a transient release of FSH and LH then strong feedback inhibition, resulting in cessation of testosterone production |
drugs ending in -inib | small molecules that INhIBit tyrosine kinases |
drugs ending in -umab | hUManized ABs that are altered genetically so as not to produce an anti-mouse neutralization response |
drugs ending in -ximab | "X out the mouse Ab", drugs that are chimerized to contain human Fc region |
imatinib (Gleevec) | specific inhibitor of bcr-abl oncogene for tx of chronic myelogenous leukemia (CML) |
bevacizumab (Avastin) | monoclonal Ab against VEGF, inactivates it and solid tumors fail to grow due to insufficient vascularization. side effects include slow wound healing and increased bleeding |
interleukin-2 | stimulates the generation of killer T cells that attack malignant metastatic melanoma and other leukemias |
thalidomide | downregulates IL-6, VEGF and TNF synthesis, important in the tx of multiple myeloma. also now for leprosy and MS |
bortezomib | inhibits the proteasome that would normally destroy IkappaB and free it from NFkappaB so it can promote growth genes within the nucleus |
Tretinoin | is ATRA that binds to RAR, which dimerizes with RXR to displace a transcription inhibitor and promote differentiation of myeloid precursors; first line tx for acute promyelocytic leukemia (APL); ATRA syndrome - pulmonary infiltration and resp distress |
colony stimulating factors | inreases the # of nl blood cells, allowing more aggressive use of cytotoxic agents with fewer effects on bone marrow cells; include erythropoietin, granulocyte CSF and granulocyte-macrophage CSF |